Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial
Daryoush Hamidi Alamdari, Ahmad Bagheri Moghaddam, Shahram Amini, Mohammad Reza Keramati, Azam Moradi Zarmehri, Aida Hamidi Alamdari, Mohammadamin Damsaz, Hamed Banpour, Amir Yarahmadi, George Koliakos
Topics & Concepts
Methylene blueCritically illCoronavirus disease 2019 (COVID-19)Clinical trialMedicinePhase (matter)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCysteineChemistryVitaminIntensive care medicinePharmacologyInternal medicineVirologyBiochemistryOrganic chemistryOutbreakDiseasePhotocatalysisEnzymeInfectious disease (medical specialty)CatalysisCOVID-19 Clinical Research StudiesVitamin C and Antioxidants ResearchLong-Term Effects of COVID-19